Jacque J. Sokolov, MD, is chairman and chief executive officer of SSB, a diversified US based healthcare company with four strategic business units: 1) SSB Solutions (Management Consulting/Advisory Services - 150+ markets); 2) SSB Investment Funds (Private/Captive Healthcare Funds); 3) SSB Financial Services/Healthcare Community Development Group-HCDG (New Markets Tax Credits, Opportunity Zone Development, etc.); and 4) SSB Governmental Services (Veteran’s Accountable Care Group-VACG).
Following his formal training as an academic cardiologist, Dr. Sokolov has had the opportunity to serve as board director, corporate officer and advisor in multiple healthcare sectors including Health Plans/Large Employers (ERISA), Hospitals/Hospital Systems, Physician Practice Management Organizations/Group Practices, Clinically Integrated Organizations (CIOs/ACOs), Pharmaceutical Companies, Device Companies, Biotechnology Companies and Private Equity/Venture Entities. He started his career as vice president for Healthcare and Chief Medical Officer for Southern California Edison Corporation (NYSE: SCE). Dr. Sokolov currently serves or has served in multiple board capacities for Public Companies including Hospira (NYSE: HSP), MedCath (NASDAQ: MDTH), and PhyAmerica (NYSE: ERDR); Private Companies including GlobalMed, Zoonie(SMG), MyHealthDirect, NeuLife Neurological Services (NeuLife), Calviri, AKOS, the Trill Project and SSB wholly owned companies; and nonprofit organizations including Phoenix Children’s Hospital, The Health Futures Council at ASU, The Executive Committee of the Board of Councilors for the USC School of Pharmacy, The Skandalaris Center National Council for Washington University in St. Louis, The National Health Foundation, the American College of Medical Quality, the National Fund for Medical Education, and the National Business Group on Health and the White House Health Project.
Dr. Sokolov received his BA and MD from the University of Southern California and completed his internal medicine residency at the Mayo Graduate School of Medicine followed by his fellowship in cardiovascular diseases/nuclear cardiology from the University of Texas-Southwestern Medical School.